16.09.2011 • News

DuPont CEO Ellen Kullman Releases Statement On America Invents Act

DuPont's Chair and CEO Ellen Kullman said in a statement that the America Invents Act will help the company more quickly convert its almost $2 billion per year investment in research and development into innovations the company can bring to market with strong patent protection.

Ellen Kullman attended the signing of The America Invents Act (HR 1249) by U.S. President Barack Obama today. Kullman is a member of the President's Council on Jobs and Competitiveness.

Ellen Kullman said, "The Act will speed R&D investment, new product development and the creation of jobs. It also will align the U.S. patent system more effectively with those of our global trading partners."

DuPont

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Article

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.